Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c1640
Identifier NCT05912712
Trial Title Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum for the Topical Treatment of Rectal Mucosal Ulcers
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis Chronic Moderate|Ulcerative Colitis Chronic Severe|Rectal Ulcer
Interventions OTHER: Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum Treatment|OTHER: Autologous Platelet-poor Plasma (PPP) and Thrombin Coagulum Treatment|DRUG: Mesalazine Suppository Treatment|BIOLOGICAL: Infliximab Treatment
Participant Information
Sponsor Xijing Hospital of Digestive Diseases
City Xi'an
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2023-07-01
Primary Completion Date 2025-06-30
Completion Date 2025-12-31